Brazil
Corporate
The European Commission, European Medicines Agency (EMA) and the Brazilian Health Regulatory Agency (ANVISA) have a confidentiality arrangement in place since 2021, allowing the exchange of confidential information as part of their regulatory and scientific processes.
The European Commission, EMA and ANVISA signed a confidentiality arrangement in 2021. It is valid for an indefinite period of time, unless terminated by either party:
Working arrangement between EMA, Directorate-General Health and Food Safety (DG SANTE) and the Brazilian Health Regulatory Agency (ANVISA) for the exchange of non-public information on medical/medicinal products
The confidential information that EMA and ANVISA can share includes: